Valeant Pharmaceuticals International Inc
(Toronto: VRX)
145.21
+1.21
+0.84%
After Hours :
145.12
-0.09
-0.06%

Open

144.05

Previous Close

144.00

Volume (Avg)

350.70K (483.24K)

Day's Range

142.83-145.70

52-wk Range

107.30-170.45

Market Cap.

48.78B

Dividend Rate ( Yield )

-

Beta

0.54

Shares Outstanding

333.57M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Drug Manufacturers – Specific & Generic
Highlights
Analyst Recommendation: Buy
    • Revenue

    • 6.50B

    • Net Income

    • -975.86M

    • Market Cap.

    • 48.78B

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -9.91

    • PEG (Price/Earnings Growth) Ratio

    • 0.71

    • Beta

    • 0.54

    • Forward P/E

    • 11.71

    • Price/Sales

    • 5.80

    • Price/Book Value

    • 8.20

    • Price/Cashflow

    • 31.35

      • EBITDA

      • 1.74B

      • Return on Capital %

      • -3.13

      • Return on Equity %

      • -13.62

      • Return on Assets %

      • -3.13

      • Book Value/Share

      • 19.86

      • Shares Outstanding

      • 333.57M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-date)

      • 0.11 (2010-08-30)

      • Dividend Declaration Date

      • 2010-08-06

      Analyst Recommendation
      2014-10-21
      Buy
        • 1-year Price Target

        • 203.72

        • Credit Rating

        • UR+

        • Analysts

        • 12

        • EPS Estimate

        • -

        • Cashflow Estimate

        • 15.11

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

          • Sales (Revenue)

            Q/Q (last year)

          • 86.30

          • Net Income

            YTD/YTD (last year)

          • -

          • Net Income

            Q/Q (last year)

          • 1,064.80

          • Sales (Revenue)

            5-year Annual Average

          • 50.10

          • Net Income

            5-year Annual Average

          • -

          • Dividends

            5-year Annual Average

          • -

          • Profit Margins (%)

          • Company

            • Gross Margin

            • 67.99

            • Pre-Tax Margin

            • -14.52

            • Net Profit Margin

            • -9.91

            • Average Gross Margin

              5-year Annual Average

            • 69.80

            • Average Pre-tax Margin

              5-year Annual Average

            • -6.70

            • Average Net Profit Margin

              5-year Annual Average

            • -1.60

            • Financial Ratios

            • Company

              • Debt/Equity Ratio

              • 3.24

              • Current Ratio

              • 2.07

              • Quick Ratio

              • 0.92

              • Interest Coverage

              • -0.09

              • Leverage Ratio

              • 5.31

              • Book Value/Share

              • 17.80

              • Price Ratios

              • Company

                • Current P/E Ratio

                • -55.87

                • P/E Ratio 5-Year High

                • -67.71

                • P/E Ratio 5-Year Low

                • -5.47

                • Price/Sales Ratio

                • 5.59

                • Price/Book Value

                • 7.91

                • Price/Cash Flow Ratio

                • 31.35

                • Key Metrics

                • Company

                  • Shares Short

                    as of -

                  • -

                  • Short Ratio

                    as of -

                  • -

                  • Short % of Float

                    as of -

                  • -

                  • Shares Short

                    prior month

                  • -

                  • Trailing Annual Dividend Yield

                  • -

                  • 5-Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Pay-out Ratio

                    • 0.00

                    • Dividend Date

                    • 2010-08-06

                    • Ex-Dividend Date

                    • 2010-08-30

                    • Last Split Factor

                      new per old

                    • -

                    • Last Split Date

                    • -

                    • Key Metrics

                    • Company

                      • Return on Equity %

                        (5-year Average)

                      • -13.62

                        (-2.40)

                      • Return on Assets %

                        (5-year Average)

                      • -3.13

                        (0.60)

                      • Return on Capital %

                        (5-year Average)

                      • -0.33

                        (-1.70)

                      • Income/Employee

                      • -

                      • Inventory Turnover

                      • 3.35

                      • Asset Turnover

                      • 0.32

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      -461.38M
                      Operating Margin
                      -7.10
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      31.35
                      Ownership

                      Institutional Ownership

                      96.07%

                      Top 10 Institutions

                      39.17%

                      Mutual Fund Ownership

                      33.23%

                      Float

                      82.08%

                      5%/Insider Ownership

                      -

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Sequoia Fund

                      •  

                        11,309,482

                      • -0.09

                      • 3.37

                      • T. Rowe Price Growth Stock Fund

                      •  

                        3,968,200

                      • 25.22

                      • 1.18

                      • iShares S&P/TSX 60

                      •  

                        3,047,724

                      • 9.62

                      • 0.91

                      • OMGB Orbis Global Equity USD

                      •  

                        2,470,703

                      • 25.28

                      • 0.74

                      • JPMorgan Large Cap Growth

                      •  

                        2,465,200

                      • 0.00

                      • 0.73

                      • T. Rowe Price Health Sciences Fund

                      •  

                        2,332,400

                      • 11.73

                      • 0.70

                      • Vanguard Total Intl Stock Idx Fund

                      •  

                        1,911,280

                      • 1.94

                      • 0.57

                      • Davis New York Venture Fund

                      •  

                        1,763,700

                      • 0.00

                      • 0.53

                      • Fidelity Canadian Balanced Class

                      •  

                        1,672,528

                      • 0.00

                      • 0.53

                      • Principal MidCap Fund

                      •  

                        1,562,799

                      • 0.77

                      • 0.47

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Ruane, Cunniff & Goldfarb Inc

                      •  

                        34,298,384

                      • +0.24%

                      • 10.23

                      • Valueact Capital Management, L.p.

                      •  

                        18,928,899

                      • 0.00%

                      • 5.64

                      • T. Rowe Price Associates, Inc.

                      •  

                        16,455,707

                      • +17.07%

                      • 4.91

                      • Fidelity Management and Research Company

                      •  

                        12,999,967

                      • -35.59%

                      • 3.89

                      • Viking Global Investors LP

                      •  

                        11,830,932

                      • +27.27%

                      • 3.53

                      • Lone Pine Capital LLC

                      •  

                        10,089,450

                      • +14.44%

                      • 3.01

                      • BMO Asset Management Inc.

                      •  

                        7,779,802

                      • -2.42%

                      • 2.32

                      • Toronto-Dominion Bank

                      •  

                        7,041,461

                      • -9.36%

                      • 2.11

                      • Brave Warrior Advisors LLC

                      •  

                        6,050,442

                      • +8.19%

                      • 1.80

                      • MFS Investment Management K.K.

                      •  

                        5,797,126

                      • -1.07%

                      • 1.73

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Drug Manufacturers – Specific & Generic

                      Type

                      High Yield

                      Style

                      Large Growth

                      Valeant Pharmaceuticals International Inc was formed on 29th March, 1994 and was formerly known as Biovail Corporation. It is a multinational, specialty pharmaceutical and medical device company that develops, manufactures, and marke...morets a range of branded, generic and branded generic pharmaceuticals, over-the-counter products "OTC", and medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices, which are marketed directly or indirectly in over 100 countries. The Company operates in two segments; Developed Markets and Emerging Markets. In the Developed Markets segment, it focuses its efforts in the eye health, dermatology, and neurology therapeutic classes. The Developed Markets segment consists of four reporting units based on geography, namely;...more U.S., Canada and Australia, Western Europe, and Japan. In the Emerging Markets segment, it focuses on branded generics, OTC products, and medical devices. The Emerging Markets segment consists of three reporting units based on geography, namely; Central & Eastern Europe, Middle East and North Africa, Latin America, and Asia & South Africa. Its principal pharmaceutical products are; Wellbutrin XL®, Xenazine®, Zovirax® Cream, Zovirax®, Lotemax®, Arestin® and Prolensa®. Its principal OTC products are; PreserVision®, ReNu Multiplus®, Ocuvite®, Artelac™, and CeraVe®. The Company relies on a combination of contractual provisions, confidentiality policies and procedures and patent, trademark, copyright and trade secrecy laws to protect the proprietary aspects of its technology and business. Its top four geographic markets are; the U.S. and Puerto Rico, Canada, Poland and Russia. The Company competes with specialty and other pharmaceutical companies, medical device companies, biotechnology companies, OTC companies and generic manufacturers, in the U.S., Canada, the EU and in other countries in which it market its products. The principal raw materials, including active pharmaceutical ingredient, used by the Company "or its third party manufacturers" for its various products are purchased in the open market or are otherwise available from several sources. The Company is subject to extensive U.S. federal and state health care marketing and fraud and abuse regulations, such as the federal False Claims Act, federal and provincial marketing regulation in Canada and similar regulations in foreign countries in which it may conduct its business.lessless

                      Key People

                      J. Michael Pearson

                      CEO/Chairman of the Board/Director

                      Mr. Howard Schiller

                      CFO/Chief Accounting Officer/Director/Executive VP

                      Laizer D. Kornwasser

                      Executive VP/Other Corporate Officer

                      Mr. Robert Roswell Chai-Onn

                      Executive VP/General Counsel/Other Corporate Officer/Other Executive Officer

                      Mr. Brian M. Stolz

                      Executive VP, Divisional/Other Executive Officer

                      • Valeant Pharmaceuticals International Inc

                      • 2150 Street Elzéar Boulevard West

                      • Laval, QC H7L 4A8B

                      • CAN.Map

                      • Phone: +1 514 744-6792

                      • Fax: +1 514 744-6272

                      • valeant.com

                      Incorporated

                      1994

                      Employees

                      17,200

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing in to my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: